Daily Judi: Thursday, January 5, 2023
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
After over a decade of research, and with more than 600 million doses of mRNA vaccines administered during the COVID-19 pandemic in the United States, MIT Technology Review explores what may be next for mRNA.
Hayley Virgil examines hyper-local care and targeted therapies in community oncology practices, the potential for more clinical trial opportunities, and how that may address inequality. (CancerNetwork)
Meanwhile, for the American Association of Critical-Care Nurses, Miranda Scoggins, MSN, RN, PCCN, CCRN, discusses best practices, standards, and the importance of diversity in clinical trials.
Our Culture
“I work mainly with one CRO, and they thank us for being proactive, and for our precise attention. We get a lot of appreciation from their whole team as we help them with their deliverable.”
–Jess, Program Manager
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
